SAN DIEGO–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/AI?src=hash” target=”_blank”gt;#AIlt;/agt;–Interpreta,
Inc., an analytics company that intelligently synchronizes
healthcare to improve quality, announced today that it has added Dr.
Norman Winarsky, co-founder and board member of Siri®, as Vice President
of Artificial Intelligence and Natural Language Analytics. Dr. Winarsky
will lead Interpreta’s medical AI strategy, overseeing development of
voice, image, and natural language interpretation capabilities for the
company.

Dr.
Winarsky is the past President of SRI Ventures, responsible for
creating SRI’s highest value opportunities, including Siri, which is
deployed on all Apple® products with an estimated one billion users.
Over 70 ventures have been launched from SRI, having a market value of
over $50 billion.

“Dr. Winarsky is a global pioneer in AI and natural language
understanding. His vast body of work in disruptive technologies makes
him a great addition to our executive team as Interpreta develops AI and
natural language capabilities,” said Interpreta
Founder and CEO Ahmed Ghouri, M.D. “We’re truly honored to have him
join our team.”

Dr. Winarsky is also a lecturer at Stanford Graduate School of Business,
where he formerly was a Visiting Scholar. He is co-author of “If You
Really Want to Change the World: A Guide to Creating, Building, and
Sustaining Breakthrough Ventures,” published by Harvard Business Review.
He was Chairman of the University of Chicago Visiting Committee for the
Physical Sciences, a member of the National Academy Committee on
Forecasting Future Disruptive Technologies, and a National Science
Foundation Fellow. He received a Ph.D. in mathematics from the
University of Chicago, and was also an invited member of the mathematics
department of the Institute for Advanced Study in Princeton. In 2000,
Dr. Winarsky and his team received an Emmy Award for outstanding
achievement in technological advancement, relating to work in HDTV. He
was also recognized with RCA’s highest honor, the Sarnoff Award.

“Interpreta has developed an impressive predictive analytics engine that
streamlines and interprets clinical and genomic data at the real-time
speed of clinical workflow. With the addition of AI and natural language
technologies, Interpreta users will have access to dynamic real-time
data, and will be better able to navigate clinical care as it unfolds at
the bedside,” said Dr. Winarsky.